Table 1 Characteristics of focus group participants
Characteristics | N | % |
|---|---|---|
Gender | ||
Male | 7 | 21 |
Female | 27 | 79 |
Age range | ||
18–29 | 7 | 21 |
30–39 | 6 | 18 |
40–49 | 7 | 21 |
50–59 | 6 | 18 |
> 60 | 8 | 24 |
Used antidepressant(s) | ||
Paroxetine | 13 | 38 |
Venlafaxine | 9 | 26 |
Sertraline | 4 | 12 |
Mirtazapine | 3 | 9 |
Citalopram | 2 | 6 |
Escitalopram | 2 | 6 |
Fluoxetine | 2 | 6 |
Fluvoxamine | 2 | 6 |
Therapy status | ||
Current user | 31 | 91 |
Past user | 3 | 9 |
Initial prescriber | ||
Psychiatrist | 21 | 62 |
General practitioner | 13 | 38 |
Self-reported indication | ||
Depression | 15 | 44 |
Anxiety | 5 | 15 |
Anxiety and depression | 12 | 35 |
Other | 2 | 6 |
Duration of SGA usage | ||
0–6 months | 3 | 9 |
6 months – 1 year | 4 | 12 |
1–5 years | 11 | 32 |
5–10 years | 7 | 21 |
> 10 years | 9 | 26 |